Cargando…

Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection from a High-volume UK Centre Compared with a National Data Set

BACKGROUND: Retroperitoneal lymph node dissection (RPLND) is essential for the treatment of metastatic germ cell tumours of the testis. Recommendations on the referral and management of complex urological cancers in the UK includes centralisation of services to regional centres. OBJECTIVE: To review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pearce, Adam Kieran, Manson-Bahr, David, Reid, Alison, Huddart, Robert, Mayer, Erik, Nicol, David L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Testis Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546923/ https://www.ncbi.nlm.nih.gov/pubmed/34723218 http://dx.doi.org/10.1016/j.euros.2021.09.005

Ejemplares similares

Nerve-sparing Robot-assisted Retroperitoneal Lymph Node Dissection: The Monoblock Technique
por: Afferi, Luca, et al.
Publicado: (2021)

Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour
por: Jay, Alexander P.M., et al.
Publicado: (2021)

DDX4-EGFP transgenic rat model for the study of germline development and spermatogenesis (†)
por: Gassei, Kathrin, et al.
Publicado: (2017)

The SMC5/6 Complex Is Involved in Crucial Processes During Human Spermatogenesis(1)
por: Verver, Dideke E., et al.
Publicado: (2014)

Different expression patterns of sperm motility-related genes in testis of diploid and tetraploid cyprinid fish(†)
por: Hu, Fangzhou, et al.
Publicado: (2017)

Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study
por: Haugnes, Hege S., et al.
Publicado: (2021)

Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial
por: Mego, Michal, et al.
Publicado: (2021)

Long-term Testis Cancer Survivors in Canada—Mortality Risks in a Large Population-based Cohort
por: Lavi, Arnon, et al.
Publicado: (2020)

Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors
por: Gariscsak, Peter J., et al.
Publicado: (2022)

Increase and Plateauing of Testicular Cancer Incidence in Austria—A Time Trend Analysis of the Past Four Decades
por: Brönimann, Stephan, et al.
Publicado: (2023)

Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Testicular Cancer: A Single Center Experiences
por: Nowroozi, Mohamadreza, et al.
Publicado: (2015)

Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer
por: Singh, Amitabh, et al.
Publicado: (2017)

Editorial Comment: Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes
por: Guimarães, Gustavo Cardoso
Publicado: (2020)

Outcomes following retroperitoneal lymph node dissection in postchemotherapy residual masses in advanced testicular germ cell tumors
por: Singh, Prabhjot, et al.
Publicado: (2016)

Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer – a single center analysis
por: Busch, Jonas, et al.
Publicado: (2012)

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)
por: Huddart, Robert A., et al.
Publicado: (2015)

Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study
por: Cakir, Omer Onur, et al.
Publicado: (2021)

Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative Review
por: Kaufmann, Ernest, et al.
Publicado: (2022)

A retrospective analysis of patients undergoing postchemotherapy retroperitoneal lymph node dissection and metastasectomy in advanced nonseminomatous germ cell tumors
por: Malik, Kanuj, et al.
Publicado: (2020)

Retroperitoneal Lymph Node Dissection in Colorectal Cancer with Lymph Node Metastasis: A Systematic Review
por: Fadel, Michael G., et al.
Publicado: (2023)

Retroperitoneal lymph node dissection for germ cell tumour
por: Tran, Vy, et al.
Publicado: (2020)

Preservation of Ejaculatory Function After Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) in Patients With Testicular Cancer: Template vs. Bilateral Resection
por: Hiester, Andreas, et al.
Publicado: (2019)

Serum Small RNA Sequencing and miR-375 Assay Do Not Identify the Presence of Pure Teratoma at Postchemotherapy Retroperitoneal Lymph Node Dissection
por: Lafin, John T., et al.
Publicado: (2021)

Robotic retroperitoneal lymph node dissection for testicular cancer at a national referral centre
por: Grenabo Bergdahl, Anna, et al.
Publicado: (2022)

The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens
por: Kremer, Lara, et al.
Publicado: (2021)

Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma: Results from a Prospective Lymph Node Mapping Study
por: Bobjer, Johannes, et al.
Publicado: (2023)

Laparoscopic retroperitoneal lymph node dissection for testicular cancer
por: Hillelsohn, Joel H., et al.
Publicado: (2012)

Outpatient robotic assisted retroperitoneal lymph node dissection
por: Basourakos, Spyridon P., et al.
Publicado: (2022)

Robotic retroperitoneal lymph node dissection in colorectal cancer
por: Othman, Bushra, et al.
Publicado: (2022)

Laparoscopic retroperitoneal lymph node dissection versus open retroperitoneal lymph node dissection for testicular cancer: A comparison of clinical and perioperative outcomes
por: Shishido, Toshihide, et al.
Publicado: (2022)

Re: Singh A et al. Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9
por: Temiz, Mustafa Zafer, et al.
Publicado: (2018)

Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
por: Hu, Brian, et al.
Publicado: (2018)

Robot assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor
por: Dogra, Prem Nath, et al.
Publicado: (2013)

Robot assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor
por: Cost, Nicholas G.
Publicado: (2013)

Robot assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor
por: Ercole, Cesar E., et al.
Publicado: (2014)

Robot - assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor
por: Torricelli, Fabio C. M., et al.
Publicado: (2017)

Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer
por: Li, Peiyong, et al.
Publicado: (2023)

Surgery for retroperitoneal relapse in the setting of a prior retroperitoneal lymph node dissection for germ cell tumor
por: Gotto, Geoffrey T., et al.
Publicado: (2010)

Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell Tumors
por: Lewin, Jeremy, et al.
Publicado: (2018)

Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma
por: Iida, Noriho, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pb3brd52g0glej289pdl8tbv8o